Dyslipidemia in seven Latin American cities: CARMELA study.

  title={Dyslipidemia in seven Latin American cities: CARMELA study.},
  author={Ra{\'u}l Vinueza and Carlos Pablo Boissonnet and M{\'o}nica Acevedo and Felipe Uriza and Francisco Jose Benitez and Honorio Silva and Herman Schargrodsky and Beatriz Marcet Champagne and Elinor Wilson},
  journal={Preventive medicine},
  volume={50 3},
OBJECTIVE The objective of this study was to describe the prevalence of dyslipidemia in the CARMELA study population. METHODS CARMELA was a cross-sectional study of cardiovascular risk conducted between September 2003 and August 2005 in adults (aged 25 to 64 years) living in Barquisimeto (n=1,824), Bogotá (n=1,511), Buenos Aires (n=1,412), Lima (n=1,628), Mexico City (n=1,677), Quito (n=1,620), and Santiago (n=1,605). Dyslipidemia was defined as the presence of one or more of the following… CONTINUE READING